ST. CHARLES, MO (KTVI) - SSM Health St. Joseph Hospital – St. Charles is one of few hospitals in the region to utilize a new technology for certain cardiovascular procedures – a stent designed to completely dissolve inside the body.
The Abbott Absorb Bioresorbable Vascular Stent functions like a standard metallic stent by opening blocked arteries in the heart and restoring blood flow. But unlike a metallic stent, it does not leave behind a permanent implant, allowing arteries to return back to 100 percent normal functionality. The product recently became approved for use by the U.S. Food & Drug Administration.
Dr. Ali Ziaee conducted the hospital’s first procedure in September, using the stent on a younger patient who had a blocked artery that was suitable for the bioresorbable stent. Dr. Ziaee says the bioresorbable stent is a good option for younger patients needing heart procedures, but is ideal only for a relatively small patient population.
The bioresorbable stent has other advantages over its standard metal cousin:
· Following surgery it does not show up as an artifact on imaging procedures such as CT scans;
· Its dissolving characteristic eliminates risk of future drawbacks occasionally seen in metal stents such as micro-fractures or tissue buildup.
To date, the stent has been successfully used at SSM Health St. Joseph Hospital on more than a half-dozen patients, all of whom have experienced positive outcomes.
To find out more about Dr. Ziaee, click here.